![Joseph Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Miller
Direttore Finanziario/CFO presso
LB PHARMACEUTICALS INC
Patrimonio netto: 9 M $ in data 30/09/2026
Profilo
Mr. Joseph M.
Miller, CPA, is a Chief Financial Officer at LB Pharmaceuticals, Inc. Mr. Miller was previously employed as a Chief Financial & Accounting Officer by Aurinia Pharmaceuticals, Inc., a Vice President-Finance by Sucampo Pharmaceuticals LLC, a Senior Director-Accounting by Qiagen Genomics, Inc., a Senior Director-Accounting by QIAGEN NV, a Chief Financial Officer & Vice President-Finance by Eppendorf Real Estate Corp., and a Chief Financial Officer & Vice President-Finance by Eppendorf-5 Prime, Inc. He also served on the board at Avalo Therapeutics, Inc. He received his undergraduate degree from Villanova University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/03/2026 | 576.421 ( 0,43% ) | 9 M $ | 30/09/2026 |
Posizioni attive di Joseph Miller
| Società | Posizione | Inizio |
|---|---|---|
| LB PHARMACEUTICALS INC | Direttore Finanziario/CFO | 02/09/2026 |
Precedenti posizioni note di Joseph Miller
| Società | Posizione | Fine |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 20/03/2026 |
| AVALO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 24/04/2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/04/2018 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Comptroller/Controller/Auditor | 01/01/2015 |
| QIAGEN N.V. | Comptroller/Controller/Auditor | 01/01/2015 |
Formazione di Joseph Miller
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Eppendorf, Inc.
 Eppendorf, Inc. BiotechnologyHealth Technology Manufactures bio-tech products | Health Technology |
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and technology in the bioscience area | Commercial Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
 Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Eppendorf-5 Prime, Inc. | |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
